Location: | London |
---|---|
Salary: | £40,201 to £43,711 per annum |
Hours: | Full Time |
Contract Type: | Fixed-Term/Contract |
Placed On: | 11th March 2025 |
---|---|
Closes: | 1st April 2025 |
Job Ref: | MED05135 |
About the role:
We are seeking a highly motivated research assistant to join our Cancer Immunology and Immunotheraphy group. The post holder will work in human cancer immunology, focusing on samples from the flagship phase III REFINE-Lung clinical trial. This unique, NIHR funded, academic led study investigates whether the frequency of immunotherapy for lung cancer can be safely reduced and offers exceptional opportunities for translational research into the biology of the immune response to cancer and the effect of anti-PD1 therapy on this. Samples from this large cohort have already been collected and are ready for analysis. The successful candidate will play a key role in the study, designing and conducting experiments to better understand why some patients respond to treatment while others do not. Additionally, you will assess whether reducing the frequency of treatment impacts the immune response and explore the potential for personalising treatment schedules based on these findings.
What you would be doing:
You will optimise and run spectral flow cytometry and other relevant assays on study samples. You will also have the opportunity to be involved in other clinical trials currently running by the team. You will be well supported by an excellent core facility and current members of the lab with relevant expertise, including bioinformatics.
What we are looking for:
We are looking for someone with;
What we can offer you:
A wonderful opportunity to engage in cutting-edge translational research, and contribute to exciting and impactful science within a warm and friendly laboratory environment where your ideas are valued, and collaboration is celebrated. There is the potential to progress to a PhD in this field.
In addition:
Further Information
This is a fulltime, fixed term position based at Hammersmith Campus (East Acton).
The project is based in the lab of Dr. Ehsan Ghorani in the department of surgery and cancer, the start date is spring 2025. Please feel free to reach out for an informal conversation (eghorani@imperial.ac.uk)
Type / Role:
Subject Area(s):
Location(s):